TEMOZOLOMIDE SUN 180 mg, hard capsule 5 capsules
Active ingredients: Temozolomide
Commercialized according to BDPMDispensing in France: Prescription only
Hard capsule5 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TEMOZOLOMIDE SUN 180 mg, gélule
- Pharmaceutical form
- gélule
- Route of administration
- orale
- Presentation description
- 5 plaquette(s) thermoformée(s) aluminium de 1 gélule(s)
- Marketing authorisation holder
- SUN PHARMACEUTICAL INDUSTRIES EUROPE (PAYS BAS)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 11 Apr 2013
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69020770CIP72678634CIP133400926786342Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TÉMOZOLOMIDEgélule | 180 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.